Morepen Laboratories enters into partnership with Vesale Pharma: Report

09 Nov 2017 Evaluate

In a bid to aggressively tap the growing probiotics market in India, Morepen Laboratories has reportedly entered into partnership with Belgium’s Vesale Pharma. The move is expected to contribute Rs 100 crore to the Indian company’s topline in five years. Moreover, the company will soon be launching four major probiotics developed by Vesale Pharma in the Indian market.

Morepen is a well-known pharma company having well equipped Research & Development Centre and is all set to seize the Generic revolution in pharma industry, by filing multiple DMFs and COS for new APIs.

Morepen Laboratories Share Price

42.42 -1.03 (-2.37%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×